B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-11-0072
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Silencing of B7-H3 Increases Gemcitabine Sensitivity by Promoting Apoptosis in Pancreatic Carcinoma

Oncology Letters
Cancer ResearchOncology
2013English

B7-H3 Silencing by RNAi Inhibits Tumor Progression and Enhances Chemosensitivity in U937 Cells

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

B7-H3 Silencing Inhibits Tumor Progression of Mantle Cell Lymphoma and Enhances Chemosensitivity

International Journal of Oncology
Cancer ResearchOncology
2015English

The Contrasting Role of B7-H3

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging

Cancer Research
Cancer ResearchOncology
2015English

STAT3 Activates MSK1-mediated Histone H3 Phosphorylation to Promote NFAT Signaling in Gastric Carcinogenesis

Oncogenesis
Cancer ResearchMolecular Biology
2020English

Icaritin Suppresses Multiple Myeloma, by Inhibiting IL-6/JAK2/STAT3

Oncotarget
Oncology
2015English

B7-H3 in Cancer – Beyond Immune Regulation

Trends in Cancer
Cancer ResearchOncology
2018English

B7-H3 Combats Apoptosis Induced by Chemotherapy by Delivering Signals to Pancreatic Cancer Cells

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy